Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 451 - 475 of 682 in total

TY027

Investigational

Vasomera

Investigational

P-2045 Re-188

Investigational

3,20-Pregnanedione

Experimental

Icotinib

Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc. was given a “May Proceed” from the US FDA to conduct a Phase I study for the...
Experimental
Investigational

Namilumab

Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.
Investigational

Fletikumab

Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis).
Investigational
Matched Synonyms: … Anti-IL-20 …
Matched Description: … Fletikumab is under investigation in clinical trial NCT01038674 (Safety and Tolerability of Anti-IL-20 …

Zamtocabtagene autoleucel

Investigational

Acetylcysteine zidrimer

Investigational

Zeluvalimab

Zeluvalimab is under investigation in clinical trial NCT04631601 (Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (Mcrpc)).
Investigational

PBCAR20A

Investigational

Thallium Tl-201

Thallium Tl-201 is under investigation in clinical trial NCT02697760 (The CZT Dynamic Myocardial Perfusion Imaging).
Investigational

Linopristin

Linopristin is an antibiotic of the streptogramin B class. It is one part of the combination product NXL 103, along with Virginiamycin M1. The combination product was under investigation in clinical trials NCT00653172 and NCT00949130 for treatment of various bacterial infections.
Investigational

BN-201

Investigational

TN-201

TN-201 is a gene therapy comprising a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene.
Investigational

T-2000

T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.
Investigational

IO-202

IO-202 is a first-in-class antibody targeting the Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB) member 4 (LILRB4). It is being investigated in cancers.
Investigational

Polifeprosan 20

Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).
Investigational
Matched Synonyms: … Polifeprosan 20 …
Matched Name: … Polifeprosan 20 …
Matched Description: … Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating …

Rubitecan

Investigational
Matched Synonyms: … 9-nitro-20(S)-camptothecin ... 9-nitro-20-(S)-camptothecin …
Matched Iupac: … nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20 …

EVT 201

EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.
Investigational

DDP-200

DDP200 is developed by Dynogen for the treatment of non-incontinent form of overactive bladder (OAB) with particular focus on both male and female patients with urinary frequency, urinary urgency and nocturia.
Investigational

AMG-208

AMG-208 has been used in trials studying the treatment of Cancer, Tumors, Oncology, Prostate Cancer, and Oncology Patients, among others.
Investigational

OCE-205

Investigational

LYT-200

LYT-200 is a fully human IgG4 monoclonal antibody directed against galectin-9.
Investigational

EDI-200

EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1.
Investigational
Displaying drugs 451 - 475 of 682 in total